Search

Your search keyword '"Rich AS"' showing total 4,978 results

Search Constraints

Start Over You searched for: Author "Rich AS" Remove constraint Author: "Rich AS" Database ScienceDirect Remove constraint Database: ScienceDirect
4,978 results on '"Rich AS"'

Search Results

1. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels

5. The PRIMED Consortium: Reducing disparities in polygenic risk assessment

6. Evaluation of elexacaftor–tezacaftor–ivacaftor treatment in individuals with cystic fibrosis and CFTRN1303K in the USA: a prospective, multicentre, open-label, single-arm trial

14. Whole-genome analysis of plasma fibrinogen reveals population-differentiated genetic regulators with putative liver roles

15. Genetics of Latin American Diversity Project: Insights into population genetics and association studies in admixed groups in the Americas

16. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

17. Metabolic regulation of the glioblastoma stem cell epitranscriptome by malate dehydrogenase 2

19. Association analysis of mitochondrial DNA heteroplasmic variants: Methods and application

20. Moving from features to functions: Bridging disciplinary understandings of urban environments to support healthy people and ecosystems

28. Pharmacological inhibition of cathepsin S and of NSPs-AAP-1 (a novel, alternative protease driving the activation of neutrophil serine proteases)

31. Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study

41. A Comparison of Commonly Utilized Diagnostic Biopsy Techniques for Pediatric Patients With Cancer: A Systematic Review by the APSA Cancer Committee

42. Proteome-wide association studies for blood lipids and comparison with transcriptome-wide association studies

50. Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

Catalog

Books, media, physical & digital resources